A guide for prescribing medicines to manage overweight and obesity - Prescribing orlistat, liraglutide and semaglutide
Key advantages: Strong blood sugar control in type-2 diabetes Clinically proven weight loss (1215% in trials) Once-weekly dosing improves patient compliance Additional metabolic benefits (BP, lipids, CV risk reduction) Common forms: Ozempic Primarily for diabetes (lower doses) Wegovy Approved for chronic weight management (higher doses) (Same molecule, different dosing & indications) Challenges for Pakistani consumers: High cost and limited availability Rising off-label use for cosmetic weight loss Side effects (GI symptoms, gallbladder issues, pancreatitis risk) Rebound weight gain if stopped without lifestyle changes Risk of counterfeit or unsupervised products Key takeaway: Semaglutide can be life-changing when used appropriately and under medical supervision but it is not a shortcut solution
Blood work can help confirm deficiencies, but consultations at The Beauty Method can identify likely candidates for B12 therapy even without testing
Drug-Drug Interactions CB-12 Injection Interacts with the Following Medicines: Chemotherapy Medicines: Medications like cisplatin and doxorubicin may interact with CB-12 Injection, potentially reducing the effectiveness of these cancer treatments due to the antioxidant properties of vitamin C
Every vial is 30ml of sterile bacteriostatic water
